The Dutch Cannabis Debate, 1968–1976

1994 ◽  
Vol 24 (3) ◽  
pp. 417-427 ◽  
Author(s):  
Marcel de Kort
Keyword(s):  
Drug Policy ◽  
Drug Control ◽  
Small Scale ◽  
Policy Alternatives ◽  
Drug Policies ◽  
Soft Drugs

Today's Dutch drug policy has acquired the reputation of standing outside the international mainstream of drug control. One of the most eye-catching aspects of the revision of the Dutch Opium Act in 1976 has been the de facto decriminalization of cannabis in small amounts. Nowadays the use of and small-scale dealing in cannabis has become normalized. This process of normalization is widely seen as a “model” for a revision of European drug policies. However, in this article the conclusion is reached that this process should not be considered as a “model.” When we examine the arguments, points of contention, and policy alternatives discussed within the Dutch ministries between 1968 and 1976, it becomes clear that the de facto decriminalization of soft drugs was more the result of the absence of policy, and of a belated adaptation to already existing circumstances, than of any rational, well-considered action.

scholarly journals Decolonizing drug policy

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Colleen Daniels ◽  
Aggrey Aluso ◽  
Naomi Burke-Shyne ◽  
Kojo Koram ◽  
Suchitra Rajagopalan ◽  
...  
Keyword(s):  
Drug Policy ◽  
Current System ◽  
Control Policy ◽  
Mass Incarceration ◽  
Drug Control ◽  
People Who Use Drugs ◽  
Power Structures ◽  
Drug Law ◽  
Drug Law Enforcement ◽  
Drug Policies

AbstractThis paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries. It demonstrates the racist and xenophobic impact of drug control policy and proposes a path to move beyond oppressive systems and structures. The ‘colonization of drug control’ refers to the use of drug control by states in Europe and America to advance and sustain the systematic exploitation of people, land and resources and the racialized hierarchies, which were established under colonial control and continue to dominate today. Globally, Black, Brown and Indigenous peoples are disproportionately targeted for drug law enforcement and face discrimination across the criminal system. These communities face higher arrest, prosecution and incarceration rates for drug offenses than other communities, such as majority populations, despite similar rates of drug use and selling among (and between) different races. Current drug policies have contributed to an increase in drug-related deaths, overdoses and sustained transnational criminal enterprises at the expense of the lives of people who use drugs, their families and greater society. This review provides further evidence of the need to reform the current system. It outlines a three-pillared approach to rebuilding drug policy in a way that supports health, dignity and human rights, consisting of: (1) the decriminalization of drugs and their use; (2) an end to the mass incarceration of people who use drugs; (3) the redirection of funding away from ineffective and punitive drug control and toward health and social programs.

scholarly journals WHO and UNDP change in leadership: What views on drug policy and harm reduction?

2017 ◽  
Vol 3 ◽  
pp. 205032451770677 ◽  
Author(s):  
Khalid Tinasti ◽  
Ann Fordham ◽  
David R Bewley-Taylor
Keyword(s):  
Sustainable Development ◽  
Human Rights ◽  
Harm Reduction ◽  
Drug Policy ◽  
Drug Control ◽  
General Assembly ◽  
Special Session ◽  
Drug Policies ◽  
Un General Assembly

The UN General Assembly Special Session on drugs held in April 2016 has been organized by the international drug control entities, but has confirmed the inclusion of other UN agencies in the global debates on drugs. Out of these, WHO and UNDP have played a major role in linking drug policy with the priorities of protecting human rights and promoting sustainable development. In May 2017, the leadership of both agencies will change. This letter reviews the aspiring leaders of these agencies’ positions on drug policies through existing literature, providing more clarity on their past or current commitment to the issue of drug policy and harm reduction stakeholders.

Deploying Plural Drug Policies after the ‘War on Drugs’: A Geographical Perspective

2019 ◽  
Vol 0 (0) ◽  
Author(s):  
Tim Hall
Keyword(s):  
Drug Policy ◽  
Policy Reform ◽  
Research Priorities ◽  
War On Drugs ◽  
Drug Markets ◽  
Policy Regime ◽  
Policy Alternatives ◽  
Drug Policies ◽  
Evidence Gathering ◽  
Drug Policy Reform

Abstract There is a growing consensus that acknowledges the failings of the prohibitionist ‘war on drugs’ model of international drug policy. Concomitant drug policy reform literatures have been characterized by the advocacy of policy pluralism, experimentation, evidence gathering/evaluation and the avoidance of drug fetishization. This paper builds upon these literatures and explores some of the complexities of drug policy pluralization, including challenges associated with drug policy asymmetries and repatriation and the, largely unexplored, potentials of deploying drug policies in combination. It argues that the drug policy reform literature has tended to favour evaluation of policy alternatives over discussion of their geographical deployment under a more plural international policy regime. It considers models to inform the deployment of plural drug policies. Conceptually this paper draws on geographical literatures and attempts to rethink drug markets and drug policy reform in geographically sensitive, regional and relational ways, highlighting scalar and relational challenges to drug policy pluralization. It concludes by outlining an extensive set of research priorities that speak directly to the challenges identified through this geographical lens.

scholarly journals On the biopolitics of humane drug policies: What can we learn from 19th century sobriety boards?

2021 ◽  
pp. 145507252110158
Author(s):  
Kenneth Arctander Johansen ◽  
Michel Vandenbroeck ◽  
Stijn Vandevelde
Keyword(s):  
19Th Century ◽  
Drug Policy ◽  
Policy Reforms ◽  
Chief Executives ◽  
Critical Studies ◽  
Drug Policies ◽  
Drug Dependent ◽  
And Control ◽  
The 19Th Century ◽  
Drug Policy Reform

Background: In accordance with recommendations from The United Nations’ Chief Executives Board of Coordination, several countries are in the process of reforming their punitive drug policies towards health-based approaches – from punishment to help. The Portuguese model of decriminalisation is generally seen as a good model for other countries and has been scientifically described in favourable terms, and not much scrutinised. Method: This article draws on foucauldian archaeological and genealogical approaches in order to understand and compare governance logics of the 19th century Norwegian sobriety boards and 21st century Portuguese commissions. In doing this, we problematize contemporary drug policy reform discussions that point to the “Portuguese model”, which aims to stop punishing and start helping drug-dependent people, are problematised. Findings: The Portuguese commissions investigate whether drug-using people are dependent or not. Dependency, circumstances of consumption and their economy are considered when the commission decides on penalising, assisting, or treating the person, or a combination of all this. This model was studied alongside the Norwegian sobriety boards mandated by the Sobriety Act that was implemented in 1932. Sobriety boards governed poor alcoholics. Authorities from the sobriety movement were central in creating sobriety policies that culminated in sobriety boards. The Portuguese commissions have similarities to Norwegian sobriety boards. They make use of sanctions and treatment to govern people who use illicit substances to make them abstain, with the view that this is emancipatory for these people. The different apparatuses have distinct and different ways of making up, and governing their subjects. Conclusion: This article contributes to debates on drug policy reforms and aims to investigate whether they might produce biopower effects of governance masked by an emancipatory language. There is a need for critical studies on drug policy reforms to avoid policies that maintain divisions and control marginalised populations.

scholarly journals Barriers and facilitators to adherence to national drug policies on antibiotic prescribing and dispensing in Bangladesh

2021 ◽  
Vol 14 (S1) ◽  
Author(s):  
Fosiul Alam Nizame ◽  
Dewan Muhammad Shoaib ◽  
Emily K. Rousham ◽  
Salma Akter ◽  
Mohammad Aminul Islam ◽  
...  
Keyword(s):  
Drug Policy ◽  
Group Discussion ◽  
National Policy ◽  
Barriers And Facilitators ◽  
Drug Shop ◽  
Antibiotic Prescribing ◽  
National Drug ◽  
National Drug Policy ◽  
Drug Policies ◽  
The Government

Abstract Background The National Drug Policy in Bangladesh prohibits the sale and distribution of antibiotics without prescription from a registered physician. Compliance with this policy is poor; prescribing antibiotics by unqualified practitioners is common and over-the-counter dispensing widespread. In Bangladesh, unqualified practitioners such as drug shop operators are a major source of healthcare for the poor and disadvantaged. This paper reports on policy awareness among drug shop operators and their customers and identifies current dispensing practices, barriers and facilitators to policy adherence. Methods We conducted a qualitative study in rural and urban Bangladesh from June 2019 to August 2020. This included co-design workshops (n = 4) and in-depth interviews (n = 24) with drug shop operators and customers/household members, key informant interviews (n = 12) with key personnel involved in aspects of the antibiotic supply chain including pharmaceutical company representatives, and model drug shop operators; and a group discussion with stakeholders representing key actors in informal market systems namely: representatives from the government, private sector, not-for-profit sector and membership organizations. Results Barriers to policy compliance among drug shop operators included limited knowledge of government drug policies, or the government-led Bangladesh Pharmacy Model Initiative (BPMI), a national guideline piloted to regulate drug sales. Drug shop operators had no clear knowledge of different antibiotic generations, how and for what diseases antibiotics work contributing to inappropriate antibiotic dispensing. Nonetheless, drug shop operators wanted the right to prescribe antibiotics based on having completed related training. Drug shop customers cited poor healthcare facilities and inadequate numbers of attending physician as a barrier to obtaining prescriptions and they described difficulties differentiating between qualified and unqualified providers. Conclusion Awareness of the National Drug Policy and the BPMI was limited among urban and rural drug shop operators. Poor antibiotic prescribing practice is additionally hampered by a shortage of qualified physicians; cultural and economic barriers to accessing qualified physicians, and poor implementation of regulations. Increasing qualified physician access and increasing training and certification of drug shop operators could improve the alignment of practices with national policy.

The Global Drug Policy Index: tracking national drug policies

The Lancet ◽  
2021 ◽  
Vol 398 (10313) ◽  
pp. 1788-1789
Author(s):  
Jacqui Thornton
Keyword(s):  
Drug Policy ◽  
Index Tracking ◽  
National Drug ◽  
Drug Policies
Sign in / Sign up

Export Citation Format

Share Document